Diphtheria Resurgence and Gaps in Vaccination
Diphtheria is a toxin-mediated bacterial disease. *Corynebacterium diphtheriae* usually causes it. The germ can inflame the throat and release a powerful toxin. That toxin can damage the heart, nerves, and kidneys. A grey membrane in the throat can also block breathing. The disease is preventable. Vaccination remains the main defence.
Many countries once pushed diphtheria to the edge of disappearance. Routine childhood shots did most of that work. In recent years, outbreaks have returned in several regions. Health agencies have reported clusters in places with weak immunisation systems. Conflict, migration, and missed clinic visits have widened the gaps. As a result, a disease once seen as historical has re-entered routine outbreak reports.
The vaccine works by teaching the body to neutralise diphtheria toxin. Infants usually receive it in a combined shot with tetanus and pertussis. Later booster doses keep protection from fading. Immunity is not lifelong after the primary series. Adults can lose protection if they miss boosters. Therefore, both children and adults matter in a control plan.
Vaccination gaps take several forms. Some children never start the schedule. Others start late and never complete the doses. Families may live far from a clinic. Stock-outs can interrupt supply. Rumours can also delay consent. In crowded settlements, those missed doses add up quickly.
Waning adult immunity adds a second problem. Parents and caregivers may carry the bacteria without severe illness. They can then pass it to infants who are too young for a full series. Health workers need boosters as well. Hospital exposure raises their risk. A strong programme therefore looks beyond the first year of life.
Diagnosis can lag. Early diphtheria looks like other throat infections. Laboratories may lack culture or toxin-testing capacity. Treatment should not wait for every confirmatory test when suspicion is high. Doctors give antitoxin and antibiotics. They also isolate the patient and trace contacts. Delay raises the chance of airway blockage and heart injury.
Public health response must close two loops at once. First, teams treat cases and protect contacts. Second, they find the unvaccinated and offer catch-up doses. School checks, antenatal visits, and outbreak campaigns can all help. Surveillance should also watch for toxigenic strains. Molecular typing can show whether cases are local or imported.
India’s experience shows why routine coverage still matters. National programmes have reduced diphtheria over decades. Uneven district coverage has still allowed pockets of disease. Migrant children and underserved urban settlements often fall behind. A single weak block can seed a wider cluster.
Prevention is straightforward in principle. Complete the infant series on time. Give boosters to older children and adults when due. Keep cold chains working. Train clinicians to recognise the membrane and the toxin syndrome. Then report suspected cases quickly.
Diphtheria returns when immunity falls and health systems thin out. It recedes when vaccination stays high and gaps are found early. The lesson is practical. A preventable toxin disease does not stay gone on its own. It stays gone only when coverage remains complete.